115 related articles for article (PubMed ID: 17043120)
1. Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis.
Kosowska-Shick K; Smith K; Bogdanovich T; Ednie LM; Jones RN; Appelbaum PC
Antimicrob Agents Chemother; 2006 Dec; 50(12):4191-4. PubMed ID: 17043120
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility testing of Streptococcus pneumoniae and Viridans streptococcal isolates against: quinolones, oxazolidinones and glycopeptides.
Băncescu G; Neagu AS; Radu-Popescu M; Nica M; Dascălu A; Nistor I; Bărbuceanu SF; Băncescu A
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):286-90. PubMed ID: 23077910
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.
Rodríguez-Avial I; Rodríguez-Avial C; Culebras E; Picazo JJ
Antimicrob Agents Chemother; 2005 Feb; 49(2):820-3. PubMed ID: 15673778
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain.
Rodríguez-Avial I; Rodríguez-Avial C; Culebras E; Picazo JJ
Int J Antimicrob Agents; 2007 Apr; 29(4):478-80. PubMed ID: 17296288
[No Abstract] [Full Text] [Related]
5. An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.
Flamm RK; Mendes RE; Ross JE; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):206-13. PubMed ID: 23478031
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of telithromycin against mefA and ermB erythromycin-resistant viridans streptococci isolated from bacteremia of oral origin in Spain.
Tomás I; Alvarez M; López-Meléndez C; Limeres J; Tomás M; Diz P
Oral Microbiol Immunol; 2005 Feb; 20(1):35-8. PubMed ID: 15612943
[TBL] [Abstract][Full Text] [Related]
7. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
Moet GJ; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):333-6. PubMed ID: 16989974
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.
Streit JM; Steenbergen JN; Thorne GM; Alder J; Jones RN
J Antimicrob Chemother; 2005 Apr; 55(4):574-8. PubMed ID: 15722390
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
Cerdá Zolezzi P; Rubio Calvo MC; Millán L; Goñi P; Canales M; Capilla S; Durán E; Gómez-Lus R
Int J Antimicrob Agents; 2004 Jun; 23(6):582-9. PubMed ID: 15194129
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
Gómez-Garcés JL; Alos JI; Tamayo J
Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanisms.
Wickman PA; Moland ES; Black JA; Thomson KS
Antimicrob Agents Chemother; 2006 Feb; 50(2):796-8. PubMed ID: 16436749
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates.
Molitoris D; Väisänen ML; Bolaños M; Finegold SM
Antimicrob Agents Chemother; 2006 May; 50(5):1887-9. PubMed ID: 16641470
[TBL] [Abstract][Full Text] [Related]
13. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
Jones RN; Fritsche TR; Sader HS; Ross JE
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):199-209. PubMed ID: 17908617
[TBL] [Abstract][Full Text] [Related]
14. Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
Credito K; Lin G; Appelbaum PC
Antimicrob Agents Chemother; 2007 Apr; 51(4):1508-11. PubMed ID: 17261625
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
Anderegg TR; Biedenbach DJ; Jones RN
J Antimicrob Chemother; 2002 Jun; 49(6):1019-21. PubMed ID: 12039896
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
Schito GC; Marchese A; Elkharrat D; Farrell DJ;
J Chemother; 2004 Feb; 16(1):13-22. PubMed ID: 15077994
[TBL] [Abstract][Full Text] [Related]
17. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of linezolid resistance in Germany, 2001-2002.
Brauers J; Kresken M; Hafner D; Shah PM;
Clin Microbiol Infect; 2005 Jan; 11(1):39-46. PubMed ID: 15649302
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
Watanabe S; Ito T; Hiramatsu K
J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
[TBL] [Abstract][Full Text] [Related]
20. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
Johnson AP; Mushtaq S; Warner M; Livermore DM
Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
